These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32229725)

  • 1. Natural killer cell and stroma abundance are independently prognostic and predict gastric cancer chemotherapy benefit.
    Li B; Jiang Y; Li G; Fisher GA; Li R
    JCI Insight; 2020 May; 5(9):. PubMed ID: 32229725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Microenvironment Characterization for Assessment of Recurrence and Survival Outcome in Gastric Cancer to Predict Chemotherapy and Immunotherapy Response.
    Chen Y; Sun Z; Wan L; Chen H; Xi T; Jiang Y
    Front Immunol; 2022; 13():890922. PubMed ID: 35572498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
    Zeng D; Li M; Zhou R; Zhang J; Sun H; Shi M; Bin J; Liao Y; Rao J; Liao W
    Cancer Immunol Res; 2019 May; 7(5):737-750. PubMed ID: 30842092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
    Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
    Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD66b
    Cong X; Zhang Y; Zhu Z; Li S; Yin X; Zhai Z; Zhang Y; Xue Y
    Cancer Med; 2020 Apr; 9(8):2761-2773. PubMed ID: 32096331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of prognostic gene expression signatures based on the tumor microenvironment characterization of gastric cancer.
    Sang Q; Dai W; Yu J; Chen Y; Fan Z; Liu J; Li F; Li J; Wu X; Hou J; Yu B; Feng H; Zhu ZG; Su L; Li YY; Liu B
    Front Immunol; 2022; 13():983632. PubMed ID: 36032070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
    Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
    Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
    [No Abstract]   [Full Text] [Related]  

  • 9. A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I-III colon cancer.
    Zhou R; Zeng D; Zhang J; Sun H; Wu J; Li N; Liang L; Shi M; Bin J; Liao Y; Huang N; Liao W
    EBioMedicine; 2019 Apr; 42():420-430. PubMed ID: 30917936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer.
    Jakab A; Patai ÁV; Darvas M; Tormássi-Bély K; Micsik T
    Pathol Oncol Res; 2024; 30():1611574. PubMed ID: 38645565
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study.
    Jiang Y; Liang X; Han Z; Wang W; Xi S; Li T; Chen C; Yuan Q; Li N; Yu J; Xie Y; Xu Y; Zhou Z; Poultsides GA; Li G; Li R
    Lancet Digit Health; 2021 Jun; 3(6):e371-e382. PubMed ID: 34045003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
    Ren N; Liang B; Li Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of cancer-associated fibroblasts subtype and prognostic model in gastric cancer and the landscape of tumor microenvironment.
    Zhang C; Sun D; Li C; Liu Y; Zhou Y; Zhang J
    Int J Biochem Cell Biol; 2022 Nov; 152():106309. PubMed ID: 36174922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer.
    Jiang Y; Xie J; Huang W; Chen H; Xi S; Han Z; Huang L; Lin T; Zhao LY; Hu YF; Yu J; Cai SR; Li T; Li G
    Cancer Immunol Res; 2019 Dec; 7(12):2065-2073. PubMed ID: 31615816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer.
    Duan R; Li X; Zeng D; Chen X; Shen B; Zhu D; Zhu L; Yu Y; Wang D
    Front Immunol; 2020; 11():609337. PubMed ID: 33569057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer.
    Jiang Y; Wang H; Wu J; Chen C; Yuan Q; Huang W; Li T; Xi S; Hu Y; Zhou Z; Xu Y; Li G; Li R
    Ann Oncol; 2020 Jun; 31(6):760-768. PubMed ID: 32240794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of natural killer cells with the prognosis of gastric adenocarcinoma].
    Rosso D; Rigueiro MP; Kassab P; Ilias EJ; Castro OA; Novo NF; Lourenço LG
    Arq Bras Cir Dig; 2012; 25(2):114-7. PubMed ID: 23381755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic risk model for patients with triple negative breast cancer based on stromal natural killer cells, tumor-associated macrophages and growth-arrest specific protein 6.
    Tian W; Wang L; Yuan L; Duan W; Zhao W; Wang S; Zhang Q
    Cancer Sci; 2016 Jul; 107(7):882-9. PubMed ID: 27145494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic prognostic score and nomogram based on inflammatory, nutritional and tumor markers predict cancer-specific survival in stage II-III gastric cancer patients with adjuvant chemotherapy.
    Liu X; Wu Z; Lin E; Li W; Chen Y; Sun X; Zhou Z
    Clin Nutr; 2019 Aug; 38(4):1853-1860. PubMed ID: 30075998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.